Kelly Lafaro

11PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsEpidemiological methodsPacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 05, 2026
Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer.

|Dec 05, 2025
TP53/KRAS variant allele frequency ratio predicts advanced disease in mucin-producing cystic neoplasms of the pancreas.

Ming-Tseh Lin, Elham Afghani, Marcia I Canto

|Nov 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment.

Ingmar F Rompen, Elisabetta Sereni, Joseph R Habib

|Sep 10, 2024
Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study.

Joseph R Habib, Benedict Kinny-Köster, Ammar A Javed

|Aug 14, 2024
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC.

Mari Nakazawa, Mike Fang, Tyrus Vong

|Feb 17, 2023
Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer.

Ming Cui, Sami Shoucair, Quan Liao

Pageof 2

Frequent Collaborators

6 joint publications

Jin He

3 joint publications

Richard A Burkhart

3 joint publications

Christopher R Shubert

3 joint publications

Jacquelyn W Zimmerman